4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-034538
CEO and CFO bought 1,000 shares at $13.84 ($13,840)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-12-02 | Purchase | +1,000 | $13.84 | $13,840 | 2,722,886 | D |
| Open-market purchases · 1,000 sh · avg $13.84 · $13,840 | |||||||
Loading xslF345X03/ownership.xml…